A review on the diagnosis, prevalence, and clinical impact of sarcopenia in chronic obstructive pulmonary disease (COPD) has found that sarcopenia is both prevalent and negatively impacts clinical outcomes in patients with the disease.
A review on the diagnosis, prevalence, and clinical impact of sarcopenia in chronic obstructive pulmonary disease (COPD) has found that sarcopenia is both prevalent and negatively impacts clinical outcomes in patients with the disease.
Searching 5 electronic databases, researchers analyzed data on over 9000 patients with COPD from 23 studies, 17 of which had comparative data between patients who had sarcopenia and those who did not.
“Sarcopenia had a consistently negative impact on a range of COPD-related clinical outcomes, including exercise capacity, balance quadriceps, and handgrip strength, gait speed, and physical activity levels,” the researchers wrote. “It was also associated with increased symptom burden and poorer quality of life.”
The researchers determined disparities in outcomes from a range of studies included in the analysis:
Meta-analyses revealed that patients with sarcopenia were more likely to have worse physical function (measured by balance, gait speed, strength, and general daily function assessments), lower levels of daily physical activity, and increased levels of dyspnea during daily activities.
The researchers also determined these patients had a heightened mortality risk, determined by body mass index, obstruction, dyspnea, and exercise tolerance (BODE) index, a tool used to predict-long term outcomes for these patients.
“We were not able to investigate actual mortality in those who had sarcopenia due to a lack of available evidence,” explained the researchers. “However, it is plausible that sarcopenia might associate with increased mortality in this population, considering that it associated with poorer prognosis and a higher prevalence with more severe lung disease.”
Among the 22 studies used to determine sarcopenia prevalence, more than 1 in 4 patients (27.5%) with COPD had sarcopenia, ranging from 15.5% to 34% across studies. The researchers noted that studies using muscle mass as the single criterion had significantly higher estimates of sarcopenia than studies that using combined muscle mass, strength, and/or physical performance criteria. According to the researchers, “more widespread implementation of these measures in clinical practice could help identify patients with COPD at increased risk of future healthcare use related to exacerbations.”
The prevalence of the condition was more common in men than women (41% vs 31.9%, respectively) as well as in patients who had greater disease severity.
Patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 3-4 had a prevalence of 37.6% while those with GOLD stages 1-2 had a prevalence of 19.1%.
The researchers were also unable to determine an association between sarcopenia and inflammatory or oxidative stress biomarkers.
Reference: Sepúlveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. Published online August 30, 2020. doi:10.1002/jcsm.12600
Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD
March 24th 2024This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD
March 18th 2024This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Read More
Frailty, Depression Can Affect Social Support, Self-Management in Older Patients With COPD
March 8th 2024Self-management (SM) among older patients with chronic obstructive pulmonary disease (COPD) is moderately low, and frailty and depression may partially mediate the relationship between social support and SM in these patients.
Read More